• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.

作者信息

Salmanton-García Jon, Busca Alessandro, Cornely Oliver A, Corradini Paolo, Hoenigl Martin, Klimko Nikolai, Marchesi Francesco, Pagliuca Antonio, Passamonti Francesco, Koehler Philipp, Pagano Livio

机构信息

Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.

Faculty of Medicine and University Hospital Cologne, University of Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.

出版信息

Hemasphere. 2021 Jun 25;5(7):e612. doi: 10.1097/HS9.0000000000000612. eCollection 2021 Jul.

DOI:10.1097/HS9.0000000000000612
PMID:34235404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8232068/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7805/8232068/90ba9cf98dbf/hs9-5-e612-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7805/8232068/90ba9cf98dbf/hs9-5-e612-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7805/8232068/90ba9cf98dbf/hs9-5-e612-g001.jpg

相似文献

1
EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.EPICOVIDEHA：一个用于COVID-19血液病患者流行病学研究的即用型平台。
Hemasphere. 2021 Jun 25;5(7):e612. doi: 10.1097/HS9.0000000000000612. eCollection 2021 Jul.
2
Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients.揭示隐藏负担：从EPICOVIDEHA到EPIFLUEHA，探索血液病患者呼吸道病毒感染的流行病学
Hemasphere. 2023 Oct 19;7(11):e970. doi: 10.1097/HS9.0000000000000970. eCollection 2023 Nov.
3
[Epidemiological characteristics of COVID-19 monitoring cases in Yinzhou district based on health big data platform].基于健康大数据平台的鄞州区新冠肺炎监测病例流行病学特征
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Aug 10;41(8):1220-1224. doi: 10.3760/cma.j.cn112338-20200409-00540.
4
[Retrospective analysis of nosocomial COVID-19: a comparison between patients with hematological disorders and other diseases].新型冠状病毒肺炎医院感染的回顾性分析：血液系统疾病患者与其他疾病患者的比较
Rinsho Ketsueki. 2020;61(8):857-864. doi: 10.11406/rinketsu.61.857.
5
Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.住院的 2019 冠状病毒病患者血液学参数的动态特征及其临床意义。
Clin Chem Lab Med. 2020 Jul 28;58(8):1365-1371. doi: 10.1515/cclm-2020-0411.
6
[Management of pediatric hematological diseases during the COVID-19 pandemic].[新冠疫情期间儿童血液病的管理]
Rinsho Ketsueki. 2021;62(2):125-129. doi: 10.11406/rinketsu.62.125.
7
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.高维单细胞分析鉴定 COVID-19 患者低 T3 综合征和并存血液恶性肿瘤的基因特征和免疫细胞图谱。
J Transl Med. 2021 Apr 1;19(1):139. doi: 10.1186/s12967-021-02805-6.
8
Clinical characteristics of hematological patients concomitant with COVID-19.伴有 COVID-19 的血液系统疾病患者的临床特征。
Cancer Sci. 2020 Sep;111(9):3379-3385. doi: 10.1111/cas.14544. Epub 2020 Jul 22.
9
Covid-19 and diabetes in primary care - How do hematological parameters present in this cohort?Covid-19 和初级保健中的糖尿病 - 该队列中存在哪些血液学参数？
Expert Rev Endocrinol Metab. 2021 May;16(3):147-153. doi: 10.1080/17446651.2021.1909472. Epub 2021 Apr 5.
10
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies.恢复期高免疫血浆用于治疗 COVID-19 血液病患者化疗免疫诱导的免疫缺陷。
Leuk Lymphoma. 2021 Jun;62(6):1490-1496. doi: 10.1080/10428194.2021.1872070. Epub 2021 Jan 18.

引用本文的文献

1
Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience.早期干预以及单克隆抗体与抗病毒药物联合治疗对感染SARS-CoV-2的肿瘤血液学患者的有效性：一项回顾性研究经验
Front Immunol. 2025 Mar 28;16:1524525. doi: 10.3389/fimmu.2025.1524525. eCollection 2025.
2
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.2023 - 2024年寒温带秋冬季节血液系统恶性肿瘤患者中的呼吸道病毒：EPICOVIDEHA - EPIFLUEHA报告
Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23.
3

本文引用的文献

1
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy.2021 年更新的癌症患者 COVID-19 诊治临床实践指南：基于循证医学的管理建议，涵盖诊断、病毒排出、疫苗接种和治疗。
Eur J Cancer. 2021 Apr;147:154-160. doi: 10.1016/j.ejca.2021.01.033. Epub 2021 Feb 10.
2
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.2020年3月至8月与新型冠状病毒肺炎相关的肺曲霉病
Emerg Infect Dis. 2021;27(4):1077-1086. doi: 10.3201/eid2704.204895. Epub 2021 Feb 4.
3
Design and evaluation of a data anonymization pipeline to promote Open Science on COVID-19.
Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV.
三项关于侵袭性念珠菌感染的泛欧多中心研究的见解及欧洲临床微生物与感染病学会念珠菌IV会议展望
Mycopathologia. 2024 Aug 1;189(4):70. doi: 10.1007/s11046-024-00871-0.
4
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.解读历史故事：2019冠状病毒病对血液系统恶性肿瘤患者的影响——2020年至2022年EPICOVIDEHA研究见解
EClinicalMedicine. 2024 Mar 18;71:102553. doi: 10.1016/j.eclinm.2024.102553. eCollection 2024 May.
5
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.COVID-19合并血液系统恶性肿瘤重症患者的重症监护需求及预后：EPICOVIDEHA调查结果
Infection. 2024 Jun;52(3):1125-1141. doi: 10.1007/s15010-023-02169-7. Epub 2024 Feb 22.
6
Pan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study.重症监护病房患者侵袭性真菌感染的泛印度临床登记：一项多中心前瞻性研究方案
JMIR Res Protoc. 2024 Feb 16;13:e54672. doi: 10.2196/54672.
7
Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients.揭示隐藏负担：从EPICOVIDEHA到EPIFLUEHA，探索血液病患者呼吸道病毒感染的流行病学
Hemasphere. 2023 Oct 19;7(11):e970. doi: 10.1097/HS9.0000000000000970. eCollection 2023 Nov.
8
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.SARS-CoV-2 疫苗接种和单克隆抗体对 CD19 导向的 CAR T 细胞治疗后结局的影响：一项 EPICOVIDEHA 调查。
Blood Adv. 2023 Jun 13;7(11):2645-2655. doi: 10.1182/bloodadvances.2022009578.
9
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.用于治疗血液系统恶性肿瘤的新冠患者的奈玛特韦/利托那韦：来自EPICOVIDEHA注册研究的报告
EClinicalMedicine. 2023 Apr;58:101939. doi: 10.1016/j.eclinm.2023.101939. Epub 2023 Apr 6.
10
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.接受替沙格韦单抗/西加韦单抗被动预先暴露免疫的血液系统恶性肿瘤合并 COVID-19 患者：EPICOVIDEHA 登记研究的配对分析。
J Hematol Oncol. 2023 Apr 1;16(1):32. doi: 10.1186/s13045-023-01423-7.
设计和评估 COVID-19 数据匿名化管道，以促进开放科学。
Sci Data. 2020 Dec 10;7(1):435. doi: 10.1038/s41597-020-00773-y.
4
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).COVID-19 癌症患者的循证管理：德国血液学和肿瘤医学学会传染病工作组（AGIHO）指南。
Eur J Cancer. 2020 Nov;140:86-104. doi: 10.1016/j.ejca.2020.09.009. Epub 2020 Sep 21.
5
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
6
Viral Respiratory Infections in Hematological Patients.血液学患者的病毒性呼吸道感染
Infect Dis Ther. 2020 Sep;9(3):495-510. doi: 10.1007/s40121-020-00313-6. Epub 2020 Jul 7.
7
COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis.COVID-19与癌症：汇总荟萃分析的经验教训
JCO Glob Oncol. 2020 Apr;6:557-559. doi: 10.1200/GO.20.00097.
8
Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction.新冠疫情：由于传播、严重程度及应对不力处于“惊人水平”，世界卫生组织宣布其为大流行病。
BMJ. 2020 Mar 12;368:m1036. doi: 10.1136/bmj.m1036.
9
ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studies.ECMM CandiReg-A 是一个用于暴发和流行病学研究的即用型平台。
Mycoses. 2019 Oct;62(10):920-927. doi: 10.1111/myc.12963. Epub 2019 Aug 1.
10
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.血液系统恶性肿瘤患者多重耐药菌定植与血流感染
Ann Hematol. 2018 Sep;97(9):1717-1726. doi: 10.1007/s00277-018-3341-6. Epub 2018 Apr 28.